Jaffetilchin Investment Partners’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-5,208
| Closed | -$205K | – | 413 |
|
|
2024
Q4 | $205K | Buy |
5,208
+1,889
| +57% | +$74.4K | 0.01% | 368 |
|
|
2024
Q3 | $156K | Buy |
+3,319
| New | +$156K | 0.01% | 388 |
|
|
2023
Q4 | – | Sell |
-4,949
| Closed | -$225K | – | 351 |
|
|
2023
Q3 | $225K | Buy |
4,949
+810
| +20% | +$36.8K | 0.02% | 307 |
|
|
2023
Q2 | $232K | Buy |
+4,139
| New | +$232K | 0.02% | 320 |
|
|
2022
Q3 | – | Sell |
-3,538
| Closed | -$215K | – | 318 |
|
|
2022
Q2 | $215K | Buy |
+3,538
| New | +$215K | 0.03% | 291 |
|